Fosun Pharmaceutical seeks $594 million from HK listing

Prudential agrees to buy $50 million worth of shares, bringing the total cornerstone investment to $75 million.

Fosun Pharmaceutical seeks $594 million from HK listing
Back to work: Fosun is the first new listing in Hong Kong for three months

Shanghai Fosun Pharmaceutical Group yesterday kicked off the institutional roadshow and bookbuilding for the first Hong Kong listing in three months and the biggest since Yitai Coal raised $902 million in early July. As such, the deal will be extremely important as a gauge of investor appetite for Chinese companies.

The private sector company is seeking to raise between HK$3.97 billion and HK$4.6 billion $512 million to $594 million from the sale of...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES